iShares Biotechnology ETF (NASDAQ:IBB) Shares Acquired by First Horizon Advisors Inc.

First Horizon Advisors Inc. boosted its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,193 shares of the financial services provider’s stock after purchasing an additional 115 shares during the period. First Horizon Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $298,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Glass Jacobson Investment Advisors llc grew its stake in shares of iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares in the last quarter. Values First Advisors Inc. purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at about $43,000. Tennessee Valley Asset Management Partners acquired a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $44,000. Massmutual Trust Co. FSB ADV increased its holdings in iShares Biotechnology ETF by 164.2% during the 4th quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 225 shares during the last quarter. Finally, CVA Family Office LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter valued at approximately $51,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $132.96 on Monday. The firm has a 50 day simple moving average of $133.61 and a 200-day simple moving average of $130.12. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a dividend of $0.126 per share. This represents a $0.50 annualized dividend and a yield of 0.38%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.